Correlation Between Cardiff Oncology and Reviva Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Cardiff Oncology and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardiff Oncology and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cardiff Oncology and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on Cardiff Oncology and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardiff Oncology with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardiff Oncology and Reviva Pharmaceuticals.

Diversification Opportunities for Cardiff Oncology and Reviva Pharmaceuticals

-0.56

Correlation Coefficient

Cardiff Oncology  Reviva Pharmaceuticals

Excellent diversification

The 3 months correlation between Cardiff and Reviva is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Cardiff Oncology and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and Cardiff Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardiff Oncology are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of Cardiff Oncology i.e., Cardiff Oncology and Reviva Pharmaceuticals go up and down completely randomly.

Pair Corralation between Cardiff Oncology and Reviva Pharmaceuticals

Given the investment horizon of 90 days Cardiff Oncology is expected to generate 0.82 times more return on investment than Reviva Pharmaceuticals. However, Cardiff Oncology is 1.23 times less risky than Reviva Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Reviva Pharmaceuticals Holdings is currently generating about 0.02 per unit of risk. If you would invest  221.00  in Cardiff Oncology on September 5, 2024 and sell it today you would earn a total of  38.00  from holding Cardiff Oncology or generate 17.19% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.44%
Values	Daily Returns

Cardiff Oncology  vs.  Reviva Pharmaceuticals Holding

Cardiff Oncology

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Cardiff Oncology are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent fundamental indicators, Cardiff Oncology reported solid returns over the last few months and may actually be approaching a breakup point.

Reviva Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Reviva Pharmaceuticals Holdings are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Reviva Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Cardiff Oncology and Reviva Pharmaceuticals

The main advantage of trading using opposite Cardiff Oncology and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardiff Oncology position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.

The idea behind Cardiff Oncology and Reviva Pharmaceuticals Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.